Rchr
J-GLOBAL ID：201801014668905624   Update date: Nov. 14, 2024

Suda Masayoshi

スダ マサヨシ | Suda Masayoshi
Affiliation and department：
Cedars-Sinai Medical Center Departments of Medicine Division of Endocrinology, Diabetes & Metabolism

About Cedars-Sinai Medical Center Departments of Medicine Division of Endocrinology, Diabetes & Metabolism


Job title： Research Scientist I
Other affiliations (1)：
Research field  (3)： Molecular biology ,  Cardiology ,  Internal medicine - General
Research keywords  (11)： Aging ,  Atherosclerosis ,  Diabetes ,  Heart failure ,  Angiogenesis ,  血管新生 ,  糖尿病 ,  高血圧 ,  心不全 ,  動脈硬化 ,  老化
Research theme for competitive and other funds  (14)：
  • 2024 - 2028 Understanding Cellular Senescence Biology in Aging through an Enhanced Targeting Strategy
  • 2024 - 2026 Development of cell type specific senolytics
  • 2021 - 2024 he therapeutic potential of senolysis for Alzheimer disease
  • 2021 - 2023 Elucidation of molecular mechanism of cellular senescence and development of senolytic therapy
  • 2020 - 2021 Senolytic vacciantaion for cardiovascular diseases
Show all
Papers (41)：
  • Masayoshi Suda, Karl H Paul, Utkarsh Tripathi, Tohru Minamino, Tamara Tchkonia, James L Kirkland. Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction. Endocrine Reviews. 2024
  • Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, et al. SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging. 2024
  • Masayoshi Suda, Goro Katsuumi, Tamar Tchkonia, James L Kirkland, Tohru Minamino. Potential Clinical Implications of Senotherapies for Cardiovascular Disease. Circulation journal. 2024. 88. 3. 277-284
  • Xu Zhang, Masayoshi Suda, Yi Zhu. Senolytics combat COVID-19 in aging. Nature aging. 2023. 3. 7. 762-763
  • Masayoshi Suda, Karl H Paul, Tohru Minamino, Jordan D Miller, Amir Lerman, Georgina M Ellison-Hughes, Tamar Tchkonia, James L Kirkland. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells. 2023. 12. 9
ｍore...
MISC (78)：
  • 須田 将吉, 南野 徹. 【老化と疾患-エイジング研究の進歩-】総論 セノリティクス(老化細胞除去治療). 日本臨床. 2024. 82. 1. 108-115
  • 須田 将吉, 南野 徹. 老化細胞を標的とした抗老化治療開発と皮膚老化. Aesthetic Dermatology. 2023. 33. 1. 36-46
  • 須田 将吉, 南野 徹. 【セノリティクス】老化細胞除去ワクチンによる加齢性変化の改善. 細胞. 2023. 55. 2. 84-87
  • 蕭捷倫, 勝海悟郎, 須田将吉, 清水逸平, 吉田陽子, 降旗高明, 上木裕介, 古内亮, 蕭詠てい, 唐敬遠, et al. Vaccination for senescence-associated glycoprotein ameliorates Alzheimer’s pathology and cognitive behavior in mice. 日本抗加齢医学会総会プログラム・抄録集. 2023. 23rd
  • 須田将吉, 南野徹. Elimination of senescent cells by using the immune system-Improvement of cardiovascular aging by senolytic vaccine. 医学のあゆみ. 2023. 287. 5. 367-373
ｍore...
Lectures and oral presentations  (35)：
  • Endothelial cell specific senescent cell clearance alleviated vascular stiffness and metabolic dysfunction in obese mice
    (8th International Cell Senescence Association (ICSA) Conference 2023)
  • Endothelial cell specific senescent cell clearance alleviated vascular stiffness and metabolic dysfunction in obese mice
    (2023)
  • Lysosomal stress in cellular senescence and elimination of senescent cells targeting lysosomal molecule
    (The 75th Annual Scientific Meeting of the Japan Society for Cell Biology 2023)
  • The therapeutic potential of senolysis for vascular diseases
    (The Japanese Circulation Society 2021)
  • Elimination of senescent cells targeting Senescence associated glycoprotein (SAGP) improved the atherosclerosis and diabetes
    (American Heart Association (AHA) 2020 2020)
ｍore...
Education (4)：
  • 2009 - 2012 Chiba University Graduate School of Medicine
  • 2005 - 2009 Chiba University School of Medicine
  • 2003 - 2005 The University of Tokyo Graduate School of Pharmaceutical Sciences
  • 1999 - 2003 The University of Tokyo Faculty of Pharmaceutical Sciences
Professional career (4)：
  • Bachelor (Pharmacology) (The University of Tokyo)
  • Master (Pharmacology) (The University of Tokyo)
  • M.D. (Chiba University)
  • Ph.D. (Chiba University)
Work history (11)：
  • 2024/07 - 現在 Cedars-Sinai Medical Center Departments of Medicine Division of Endocrinology, Diabetes & Metabolism Research Scientist I
  • 2021/06 - 現在 Juntendo University Cardiovascular medicine Assistant Professor
  • 2024/04 - 2024/06 Mayo Clinic College of Medicine and Science Department of Physiology Assistant Professor of Physiology
  • 2021/09 - 2024/06 Mayo Clinic Departments of Medicine and Physiology and Biomedical Engineering Research fellow
  • 2020/04 - 2021/08 Niigata University Medical and Dental Hospital Cardiovascular Medicine Assistant Professor
Show all
Awards (4)：
  • 2020/09 - 日本循環器学会 関東甲信越支部 第257回日本循環器学会関東甲信越地方会 Basic・Translational Research Award 最優秀賞
  • 2019/07 - Basic Cardiovascular sciences New Investigator Travel Award
  • 2018/12 - 日本血管生物医学会 若手研究奨励賞 最優秀賞
  • 2018/04 - 日本心血管内分泌代謝学会 若手研究奨励賞
Association Membership(s) (6)：
日本心臓病学会 ,  日本血管生物医学会 ,  日本心血管内分泌学会 ,  日本抗加齢医学会 ,  日本循環器学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM